Inno-Q-Nol UltraSorb - Innovite Health

Key Benefits At A Glance:

• Helps support the functioning of the central nervous system.
• Reduces the Frequency of Migraine headaches.
• Provides additional cognitive support if use is combined with Innovite's PQQ.
• Formulated with Ubiquinol, the biologically superior form of CoQ10.
• Strongest lipid soluble antioxidant available.
• Most circulating CoQ10 (95%) in the blood.
• Highly stabilized through a patented process from Kaneka Corporation, Japan – the world's largest CoQ10 producer and the makers of the only yeast fermented, most stable form of CoQ10.
• Especially beneficial for those who cannot efficiently convert less active forms of CoQ10 into ubiquinol.

Product Description:

Coenzyme Q10 is a vital nutrient present in mitochondria of every cell in the body. It plays a critical role in energy production within the cells of the nervous system, including the brain.
By restoring and repairing the healthy cells in your body and protecting them from free cell radicals, you will be able to reclaim your cognitive health to achieve a stronger and longer lasting wellness.
The next generation of CoQ10, Ubiquinol is the strongest lipid soluble antioxidant available.

•     Ubiquinol is the active, antioxidant form of CoQ10
•     Most circulating CoQ10 (95%) in the blood is in this activated form
•     Both Ubiquinol and Ubiquinone are forms of CoQ10 that are necessary for the production of cellular energy and life sustaining qualities.
•     Until now, most supplements available on the market contained the ubiquinone form of CoQ10.
•     Biochemically, ubiquinone must be converted by the body to the active ubiquinol form in order to start working effectively as a potent antioxidant and cellular nutrient
•     Ubiquinol is the active antioxidant form of CoQ10 and body ready for cellular energy production – no need for conversion in the body.
•     The conversion into the active antioxidant ubiquinol form is not optimal in all individuals especially those who are older (over 40 years of age), have age-related diseases (heart disease, diabetes, neurodegenerative disease) or are in highly oxidative states (athletes)
•     Research indicates that those in the categories mentioned above have lower ubiquinol levels and can benefit dramatically with ubiquinol supplementation
•     It is highly stabilized through a patented process from Kaneka Corporation, Japan – the world's largest CoQ10 producer and the makers of the only yeast fermented CoQ10.
•     Since ubiquinol is easily oxidized in the air, researchers at Kaneka spent ten years in pursuit of stabilized ubiquinol that would enhance the activity of CoQ10
•     A review of published studies on human subjects reveals that it requires very high doses of conventional CoQ10 to achieve the same levels attainable with lower amounts of ubiquinol CoQ10.

Due to CoQ10's established role in the body's energy production process, ubiquinol should increase energy, stamina and general wellness in most people, especially in those who cannot efficiently convert CoQ10 into ubiquinol. It is believed that those who are 40 and older or are affected by age-related health conditions may benefit from this pre-converted form of CoQ10 more than those who are younger.

Ubiquinone vs. Ubiquinol

Ubiquinone is the standard form of COQ10. In order to generate cellular energy your body must convert ubiquinone to ubiquinol. As we age, our ability to convert CoQ10 becomes very poor; hence the best way to achieve optimal benefits of CoQ10 is the ready-to-use activated form – Ubiquinol, the biologically superior form of CoQ10.

Compared to standard CoQ10 supplements, ubiquinol is absorbed in the bloodstream up to 8 times better; it reduces exercise-induced fatigue by 90% more and slows aging 40% better. In experimental studies ubiquinol also shown to achieve 3.75 times higher plasma concentrations after 8 hours than standard CoQ10.

Figure 1 shows how little ubiquinol is needed to provide the same blood plasma levels of CoQ10 that are achieved in response to far greater amounts of ubiquinone.
Who should consider taking Ubiquinol?

Supplementing with ubiquinol rather than standard CoQ10 (ubiquinone) is especially important for individials who may have difficulty with the natural conversion of CoQ10 to ubiquinol such as:
- The late middle-aged to elderly
- Individuals suffering from specific conditions especially related to oxidative stress including diabetics, those with liver disease and with heart disease.

Supplement Facts:

Each softgel contains:
Coenzyme Q10 (Kaneka QH® ubiquinol, from yeast fermentation) …………100 mg
Non-Medicinal Ingredients: Medium chain triglycerides, glycerin, gelatin, ascorbyl palmitate, purified water, polysorbate 80, annatto extract, soybean oil.

Free from wheat, gluten, dairy, corn, eggs, nuts, peanuts, fish, shellfish, yeast, sugar, artificial colours, flavours and preservatives.
Kaneka QH® is a trademark of Kaneka Corporation.

QUALITY, PURITY AND POTENCY GUARANTEED.

Suggested Dose And Usage:

Adults: Take 1 softgel 1-3 times daily.  For migraine prevention (adults): Take 1 softgel 2-3 times daily.  Use for a minimum of 3 months to see beneficial effects.

Warnings And Contraindications:

Consult a healthcare practitioner prior to use if you are pregnant, breastfeeding or on blood pressure medications or blood thinners.
Cautions: Do not use if the seal is broken. Keep out of reach of children. Store in a cool dry place to preserve freshness.

Notice: The products and information found on www.zwell.ca are not intended to replace professional medical advice or treatment.  These statements have been evaluated by Health Canada but have not been evaluated by the U.S. Food and Drug Administration at this point.  Our natural health supplements and products are not intended to diagnose, treat, cure or prevent any disease or medical condition.  Individual results may vary.  For the complete disclosure statement click here.

Research:

Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 2007 Feb;47(1):19-28. Epub 2006 Aug 21.

Michael V Miles, Paul Horn, Lili Miles, Peter Tang, Paul Steele, Ton DeGrauw. Bioequivalence of coenzyme Q10 from over-the-counter supplements. Nutr Res. Aug 2002;22(8):919-929.

Hectors MP et al. Stability studies of ubiquinol in plasma. Ann Clin Biochem. 2003 Jan;40(Pt 1):100-1.